Impact of comorbidities on the treatment of non-Hodgkin's lymphoma: a systematic review

Expert Review of Hematology
Catherine TerretPierre Soubeyran

Abstract

Treating non-Hodgkin's lymphoma in patients with comorbidities can be challenging because of possible interactions that may alter the treatment efficacy. We conducted a systematic review to determine the impact of comorbidities on various outcomes, evaluate the current data, and provide recommendations for future research. Twenty-one articles were selected. However, the study populations and design were greatly heterogeneous, and the quality of reporting was generally weak. The majority of studies demonstrated significant impact of comorbidity on survival, reporting poorer survival rates for patients with comorbidities compared to those with no comorbidities. However, the existing evidence is limited and of insufficient quality to establish solid conclusions and to guide treatment decisions. Prospective, well-designed studies are warranted.

References

Sep 1, 1996·Annals of Epidemiology·J M Guralnik
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
May 3, 2003·Journal of Clinical Epidemiology·Vincent de GrootLex M Bouter
May 27, 2004·JAMA : the Journal of the American Medical Association·Jay F PiccirilloEdward L Spitznagel
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William L ReadJay F Piccirillo
Nov 25, 2004·Hematology·Richard I FisherOwen A O'Connor
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnJoseph M Connors
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M HabermannSandra J Horning
Jun 11, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Tanya M WildesSteven M Devine
Jan 27, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Seth M PollackMichael R Bishop
Jul 6, 2010·Journal of Cancer Research and Clinical Oncology·Nils WinkelmannUlrich Wedding
Jan 12, 2011·Journal of Cancer Research and Clinical Oncology·Yujin KobayashiJin Takeuchi
Sep 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A M van de SchansM L G Janssen-Heijnen
Mar 1, 2012·American Journal of Hematology·Rebecca L ElstromUsama Gergis
Aug 24, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A TrebouetR Houot
Dec 1, 1970·Journal of Chronic Diseases·A R Feinstein
May 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A M van de SchansM L G Janssen-Heijnen

❮ Previous
Next ❯

Citations

May 14, 2016·Acta Clinica Belgica·Nathalie DenewetThierry Pepersack
May 22, 2017·Breast Cancer Research and Treatment·Melissa J EdwardsMarion J Kuper-Hommel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
J StairmandC Cunningham
Dermatology : International Journal for Clinical and Investigative Dermatology
Giampiero Girolomoni, Paolo Gisondi
Journal of Speech and Hearing Research
A L HollandM Stein
© 2021 Meta ULC. All rights reserved